Viewing Study NCT07201558


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-01-31 @ 5:34 AM
Study NCT ID: NCT07201558
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
None Systemic Lupus Erythematosus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult participants View
None rheumatoid arthritis View
None systemic lupus erythematosus View
None surovatamig View